Position in PRQR
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$185,094
+$165,566 QoQ
Shares Held
114,256
+678.2% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRQR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GSA CAPITAL PARTNERS LLP holds $101,563,069 across 163 Biotechnology names. PRQR ranks #125 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,831 | $2,959,983 | |
| 2 | ARDX |
Ardelyx, Inc.
|
473,061 | $2,833,635 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
178,301 | $2,285,818 | |
| 4 | NUVB |
Nuvation Bio Inc.
|
495,792 | $2,126,947 | |
| 5 | RXRX |
Recursion Pharmaceuticals, Inc.
|
669,568 | $2,055,573 | |
| 6 | WVE |
Wave Life Sciences Ltd.
|
282,719 | $2,049,712 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
90,960 | $1,979,289 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
557,085 | $1,955,368 |
All Filings in PRQR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $185,094 | 114,256 | Shares | Sole | 2026-05-08 | |
| 2025-03-31 | $19,528 | 14,683 | Shares | Sole | 2025-05-08 | |
| 2023-09-30 | $96,309 | 74,084 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $71,014 | 43,836 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $79,601 | 21,514 | Shares | Sole | 2023-02-13 | |
| 2021-09-30 | $1,146,715 | 137,003 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $413,087 | 61,289 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $172,864 | 26,152 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $200,025 | 47,625 | Shares | Sole | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||